Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BECTON DICKINSON & CO Director's Dealing 2024

May 1, 2024

30003_dirs_2024-05-01_4e2962fa-00b2-4c16-bcad-42954e1f8bdd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2024-04-30

Reporting Person: Garrison Michael David (EVP & President Medical)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-04-30 Common Stock S 1715 $232.81 Disposed 5381 Direct